Pharmaceuticals

Global G-CSF (Granulocyte Colony Stimulating Factors) Market Overview And Prospects

November 22, 2021 by The Business Research Company

Learn about the global G-CSF (granulocyte colony stimulating factors) market through The Business Research Company, which provides information on G-CSF (granulocyte colony stimulating factors) market size, G-CSF (granulocyte colony stimulating factors) market drivers and restraints, G-CSF (granulocyte colony stimulating factors) market players, the COVID-19 impact on the G-CSF (granulocyte colony stimulating factors) market, and more.

Our annual holiday sale is here! Get your discounted market research reports today.

The global G-CSF (granulocyte colony stimulating factors) market is expected to grow from $6.93 billion in 2020 to $7.37 billion in 2021 at a compound annual growth rate (CAGR) of 6.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The G-CSF market is expected to reach $9.17 billion in 2025 at a CAGR of 6%.

The increasing prevalence of cancer is expected to drive innovation in G-CSF (granulocyte colony stimulating factors), thus driving the market during the forecast period.

Request A Sample For The Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3466&type=smph

The G-CSF (Granulocyte Colony Stimulating Factors) market consists of sales of G-CSF drugs and relates services. Granulocyte colony-stimulating factor is a drug used to treat neutropenia, a disorder in which there is a lower-than-average number of white blood cells, caused by certain forms of chemotherapy.

Global G-CSF (granulocyte colony stimulating factors) market segments include:

By Type: Lenograstim (Granocyte), Filgrastim (Neupogen, Zarzio, Nivestim, Accofil), Long Acting (Pegylated) Filgrastim (Pegfilgrastim, Neulasta, Pelmeg, Ziextenco), Lipegfilgrastim (Lonquex)

By Application: Oncological Diseases, Blood Disorders, Growth Hormone Deficiencies, Chronic And Autoimmune Disorders, Others

By Product: Tablet, Capsule, Others

By Geography: The market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

TBRC’s G-CSF (granulocyte colony stimulating factors) market report covers:

Major Market Players: BioCad, Teva Pharmaceuticals, Pfizer, Intas Pharmaceuticals, Novartis AG, Stada Arzneimittel, Dong-A Socio Group, Amgen, Dr. Reddy’s Laboratories, and Celltrion Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Time Series: Five years historic (2015-20) and ten years forecast (2021-2025-2030)

The G-CSF (Granulocyte Colony Stimulating Factors) Global Market Report 2021: COVID-19 Growth and Change to 2030 is one of a series of new reports from The Business Research Company that provides G-CSF (granulocyte colony stimulating factors) market overviews, analyzes and forecasts market size, share, G-CSF (granulocyte colony stimulating factors) market players, G-CSF (granulocyte colony stimulating factors) market segments and geographies, leading competitor revenues, profiles and market shares.

TBRC’s G-CSF (granulocyte colony stimulating factors) market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Here is a list of similar reports from The Business Research Company:

Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2021

Antiemetics And Antinauseants Global Market Report 2021

Global Biologics Market

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 8897263534

Americas: +1 315 623 0293

Email: info@tbrc.info

Check out our Blog: https://blog.tbrc.info/

Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model